These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 3731677)

  • 21. Antipyrine clearance and metabolite formation: the influence of liver volume and smoking.
    Spoelstra P; Teunissen MW; Janssens AR; Weeda B; van Duijn W; Koch CW; Breimer DD
    Eur J Clin Invest; 1986 Aug; 16(4):321-7. PubMed ID: 3093244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elimination of antipyrine and its metabolites in interferon treated hepatitis C.
    Sieck JO; el-Yazigi A; Ali H; Døssing M; Saour J; Raines DA; Ernst P
    Hum Exp Toxicol; 1994 Sep; 13(9):598-601. PubMed ID: 7986571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
    Rivière JH; Back DJ; Breckenridge AM; Howells RE
    Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on theophylline metabolism: autoinduction and inhibition by antipyrine.
    Denlinger CL; Stryker KK; Slusher LB; Vesell ES
    Clin Pharmacol Ther; 1987 May; 41(5):522-30. PubMed ID: 3568537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.
    Danhof M; Krom DP; Breimer DD
    Xenobiotica; 1979 Nov; 9(11):695-702. PubMed ID: 119355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antipyrine metabolite formation and excretion in patients with chronic renal failure.
    Teunissen MW; Kampf D; Roots I; Vermeulen NP; Breimer DD
    Eur J Clin Pharmacol; 1985; 28(5):589-95. PubMed ID: 4043202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipyrine metabolism is not affected by terbinafine, a new antifungal agent.
    Seyffer R; Eichelbaum M; Jensen JC; Klotz U
    Eur J Clin Pharmacol; 1989; 37(3):231-3. PubMed ID: 2612536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.
    Danhof M; van Zuilen A; Boeijinga JK; Breimer DD
    Eur J Clin Pharmacol; 1982; 21(5):433-41. PubMed ID: 7075648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of chloroquine and primaquine on antipyrine metabolism.
    Back DJ; Purba HS; Park BK; Ward SA; Orme ML
    Br J Clin Pharmacol; 1983 Nov; 16(5):497-502. PubMed ID: 6639836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human metabolism of antipyrine labelled with 14C in the pyrazolone ring or in the N-methyl group.
    Uchino H; Inaba T; Kalow W
    Xenobiotica; 1983 Mar; 13(3):155-62. PubMed ID: 6613161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of malaria infection on antipyrine metabolite formation in the rat.
    Mansor SM; Ward SA; Edwards G
    Biochem Pharmacol; 1991 Apr; 41(8):1264-6. PubMed ID: 2009102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effect of cigarette smoking on antipyrine oxidation versus acetaminophen conjugation.
    Scavone JM; Greenblatt DJ; LeDuc BW; Blyden GT; Luna BG; Harmatz JS
    Pharmacology; 1990; 40(2):77-84. PubMed ID: 2345775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diltiazem-digoxin interaction.
    Rameis H; Magometschnigg D; Ganzinger U
    Clin Pharmacol Ther; 1984 Aug; 36(2):183-9. PubMed ID: 6744777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of propylene glycol on antipyrine clearance in humans.
    Nelson EB; Egan JM; Abernethy DR
    Clin Pharmacol Ther; 1987 May; 41(5):571-3. PubMed ID: 3568541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of isoniazid and oral contraceptive steroids on antipyrine oxidation and acetaminophen conjugation.
    Ochs HR; Greenblatt DJ; Verburg-Ochs B; Abernethy DR; Knüchel M
    Pharmacology; 1984; 28(4):188-95. PubMed ID: 6728897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats with a portacaval shunt.
    van der Graaff M; Vermeulen NP; Joeres RP; Breimer DD
    Pharmacology; 1984; 29(2):99-109. PubMed ID: 6473507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man.
    Boobis AR; Brodie MJ; Kahn GC; Toverud EL; Blair IA; Murray S; Davies DS
    Br J Clin Pharmacol; 1981 Dec; 12(6):771-7. PubMed ID: 7340879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effect of cimetidine on drug oxidation (antipyrine and diazepam) vs. conjugation (acetaminophen and lorazepam): prevention of acetaminophen toxicity by cimetidine.
    Abernethy DR; Greenblatt DJ; Divoll M; Ameer B; Shader RI
    J Pharmacol Exp Ther; 1983 Mar; 224(3):508-13. PubMed ID: 6827475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ibuprofen does not impair antipyrine clearance.
    Abernethy DR; Greenblatt DJ
    J Clin Pharmacol; 1983; 23(11-12):517-22. PubMed ID: 6662976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quinidine does not alter antipyrine metabolism.
    Bowles SK; Cardozo L; Edwards DJ
    J Clin Pharmacol; 1990 Mar; 30(3):267-71. PubMed ID: 2312782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.